Lenzilumab ELISA Kit (DY213018)

Aperçu

Numéro de catalogue	DY213018
Description	Lenzilumab ELISA Kit (DY213018) — Quantitative sandwich ELISA for Lenzilumab. Sample: Plasma, Serum. Range: 0.31-5 μg/mL. Sensitivity: 0.156 μg/ml. Highlights ●Sandwich Format — High specificity, reliable quantification. ●High Sensitivity — Optimized for low-abundance target detection. ●Ready-to-Use — Complete kit with pre-coated plates included.
Type d'échantillon	Plasma, Serum
Sensibilité	0.156 μg/ml
Plage	0.31-5 μg/mL
Numéro d'accès	P04141
Applications	ELISA
Méthode de détection	Colorimetric
Type de test	Quantitative
Retraitement	80-120%
Expédition	2-8 ℃
Stabilité et stockage	The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Spécifications	Lenzilumab
Noms alternatifs	KB-003, 1229575-09-0
Contexte	Granulocyte-macrophage colony-stimulating factor (Lenzilumab) is a ~16 kDa protein. Cytokine that stimulates the growth and differentiation of hematopoietic precursor cells from various lineages, including granulocytes, macrophages, eosinophils and erythrocytes.
Note	For Research Use Only.